Literature DB >> 16798394

Reform of drug control policy for palliative care in Romania.

Daniela Mosoiu1, Karen M Ryan, David E Joranson, Jody P Garthwaite.   

Abstract

Unrelieved pain from cancer and HIV/AIDS is a substantial worldwide public-health problem. Inadequate pain relief is partly due to excessively strict national drug-control policies that constrain medical use of essential medicines such as morphine. Romania's drug-control policies are more than 35 years old and impose an antiquated regulatory system that is based on inpatient post-surgical management of acute pain that restricts prescription authority and makes access to opioid treatment difficult for outpatients with severe chronic pain due to cancer or HIV/AIDS. A Ministry of Health palliative-care commission used WHO guidelines to assess and recommend changes to Romania's national drug control law and regulations. The Romanian parliament has adopted a new law that will simplify prescribing requirements and allow modern pain management. Achievement of adequate pain relief is a vital part of worldwide health and will be dependent on reform of antidrug regulations in many countries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798394     DOI: 10.1016/S0140-6736(06)68482-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

Review 1.  Improving the availability and accessibility of opioids for the treatment of pain: the International Pain Policy Fellowship.

Authors:  Snezana Bosnjak; Martha A Maurer; Karen M Ryan; Marta X Leon; Gabriel Madiye
Journal:  Support Care Cancer       Date:  2011-06-03       Impact factor: 3.603

2.  Do national drug control laws ensure the availability of opioids for medical and scientific purposes?

Authors:  S Asra Husain; Marty Skemp Brown; Martha A Maurer
Journal:  Bull World Health Organ       Date:  2013-11-26       Impact factor: 9.408

3.  Using a morphine equivalence metric to quantify opioid consumption: examining the capacity to provide effective treatment of debilitating pain at the global, regional, and country levels.

Authors:  Aaron M Gilson; Martha A Maurer; Karen M Ryan; Paul J Rathouz; James F Cleary
Journal:  J Pain Symptom Manage       Date:  2012-09-24       Impact factor: 3.612

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.